The Federal Trade Commission said Friday that it is suing three drug middlemen, accusing them of inflating insulin prices.

Cigna Group closed $14.69 short of its 52-week high ($370.83), which the company reached on September 16th.

The Federal Trade Commission (FTC) is suing pharmacy benefit managers CVS Health (CVS), Cigna Group (CI), and UnitedHealth ...

The U.S. Federal Trade Commission sued the country's three largest pharmacy benefit managers on Friday, accusing them of ...

The enforcement action is part of an escalating conflict between the FTC and the three pharmacy benefit managers that ...

The US Federal Trade Commission sued units of CVS Health Corp., Cigna Group and UnitedHealth Group Inc. on Friday, accusing ...

Shares of Cigna Group CI slid 0.24% to $355.39 Wednesday, on what proved to be an all-around poor trading session for the ...

The reductions will affect roughly 5,400 members, mostly in Florida, according to a notice to marketing agents.

The case takes aim at the major pharmacy benefit managers, agency officials said, claiming that they favored more expensive ...

The Federal Trade Commission took action Friday against the three largest pharmacy benefit managers, accusing the companies ...

Cigna Healthcare's divestiture of low-margin Medicare businesses will allow focus on employer-sponsored plans. Learn more on ...

The Federal Trade Commission has brought an administrative complaint against three of the country's largest pharmacy benefit ...